Closed
National Generic Pharmaceuticals – Project Revive
NHS England
- Value
- £1.20
- Published
- 12 Aug 2026
- Deadline
- 25 Aug 2026
- Procedure
- Not stated
- Category
- 33600000 — Pharmaceutical products
- Location
- London, UKI45, SE1 8UG, United Kingdom
- Notice reference
- 076471-2026
Requirements summary
NHS England is planning to procure generic pharmaceutical products as part of the Project Revive initiative, aiming to reactivate dormant licenses for critical supplies. The contract is intended to span from April 1, 2027, to January 31, 2029, with potential extensions.
Key requirements
- Provider of pharmaceutical products reactivating dormant licenses
- Support for supply chain resilience in secondary care
- Collaboration with MHRA and Medicines UK
- Engagement with potential new suppliers
- Contract duration of 22 months with extension options
Similar open notices
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- NHS National Framework Agreement for Macitentan & Cladribine TabletsNHS England
- Injection Equipment ParaphernaliaThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy ServicesUniversity Hospitals of Derby and Burton NHS Foundation Trust
- NEYPPC Pharmacy - Unlicensed Imported Medicines (wave 2)Leeds Teaching Hospitals NHS Trust